Stem cell and progenitor cell therapy in peripheral artery disease

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Thrombosis and Haemostasis

• Publication date

  2010-02-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH09-10-0688PMID 20174766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy

  2011cited by this paper
• Early Translation of Adipose-Derived Cell Therapy for Cardiovascular Disease

  2009cited by this paper
• Differential bone marrow stem cell mobilization by G‐CSF injection or arterial ligation in baboons

  2009cited by this paper
• The Role of Angiogenic Growth Factors in Arteriogenesis

  2009cited by this paper
• Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot.

  2009cited by this paper
• Endothelial progenitor cells are selectively mobilised immediately after coronary artery bypass grafting or valve surgery

  2009cited by this paper
• Defining the potential for cell therapy for vascular disease using animal models

  2009cited by this paper
• Collateral circulation

  2009cited by this paper
• Autologous Bone Marrow Cell Transplantation Increases Leg Perfusion and Reduces Amputations in Patients with Advanced Critical Limb Ischemia Due to Peripheral Artery Disease

  2009cited by this paper
• Reduced levels of putative endothelial progenitor and CXCR4+ cells in coronary artery disease: Kinetics following percutaneous coronary intervention and association with clinical characteristics

  2009cited by this paper
• Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study

  2009cited by this paper
• Isolation of Mesenchymal Stem Cells from Human Placental Decidua Basalis and Resistance to Hypoxia and Serum Deprivation

  2009cited by this paper
• Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.

  2008cited by this paper
• Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activity.

  2008cited by this paper
• Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth

  2008cited by this paper
• Endothelial progenitor cells: identity defined?

  2008cited by this paper
• Haematopoietic growth factors and their therapeutic use

  2008cited by this paper
• Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans

  2008cited by this paper
• Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

  2008cited by this paper
• The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia

  2008cited by this paper
• Stimulation of collateral artery growth: travelling further down the road to clinical application

  2008cited by this paper
• Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).

  2008cited by this paper
• Autologous intra-arterial infusion of bone marrow mononuclear cells in patients with critical leg ischemia.

  2008cited by this paper
• Allogeneic endometrial regenerative cells: An "Off the shelf solution" for critical limb ischemia?

  2008cited by this paper
• Aging and disease as modifiers of efficacy of cell therapy.

  2008cited by this paper
• A Novel Stem Cell Source for Vasculogenesis in Ischemia: Subfraction of Side Population Cells from Dental Pulp

  2008cited by this paper
• Treatment with Autologous Bone Marrow Mononuclear Cells in Patients with Critical Lower Limb Ischaemia. A Pilot Study

  2008cited by this paper
• Progenitor Cell Therapy in Patients With Critical Limb Ischemia Without Surgical Options

  2008cited by this paper
• Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.

  2008influential reference
• Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.

  2008cited by this paper
• Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation.

  2007cited by this paper
• Endothelial Outgrowth Cells Are Not Derived From CD133+ Cells or CD45+ Hematopoietic Precursors

  2007cited by this paper
• Peripheral endothelial progenitor cells (CD133 +) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up.

  2007cited by this paper
• Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans

  2007cited by this paper
• Good Manufacturing Practice-Compliant Expansion of Marrow-Derived Stem and Progenitor Cells for Cell Therapy

  2007cited by this paper
• Endothelial progenitor cells in cardiovascular disorders.

  2007cited by this paper
• Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

  2007cited by this paper
• Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (The TAM-PAD study)

  2007cited by this paper
• Additive effect of endothelial progenitor cell mobilization and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs.

  2007cited by this paper
• Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.

  2007cited by this paper
• Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction.

  2007cited by this paper
• Aging in the Atherosclerosis Milieu May Accelerate the Consumption of Bone Marrow Endothelial Progenitor Cells

  2007cited by this paper
• Regulation of angiogenesis by hypoxia-inducible factor 1.

  2006cited by this paper
• Epidemic obesity and type 2 diabetes in Asia.

  2006influential reference
• Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy

  2006cited by this paper
• Differential Healing Activities of CD34+ and CD14+ Endothelial Cell Progenitors

  2006cited by this paper
• Effects of Granulocyte Colony Simulating Factor on Functional Activities of Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Disease

  2006cited by this paper
• Autologous Mononuclear Stem Cell Transplantation in Patients With Peripheral Occlusive Arterial Disease

  2006cited by this paper
• Unblinded Pilot Study of Autologous Transplantation of Bone Marrow Mononuclear Cells in Patients With Thromboangiitis Obliterans

  2006influential reference
• Arteriogenesis versus angiogenesis: similarities and differences

  2006cited by this paper
• Combination of In Vivo Angiopoietin-1 Gene Transfer and Autologous Bone Marrow Cell Implantation for Functional Therapeutic Angiogenesis

  2006cited by this paper
• Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.

  2006cited by this paper
• Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

  2006cited by this paper
• Low-Energy Shock Wave for Enhancing Recruitment of Endothelial Progenitor Cells: A New Modality to Increase Efficacy of Cell Therapy in Chronic Hind Limb Ischemia

  2006influential reference
• ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent

  2006cited by this paper
• Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

  2006cited by this paper
• [Transplantation of autologous adult bone marrow stem cells in patients with severe peripheral arterial occlusion disease].

  2006cited by this paper
• Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs

  2006cited by this paper
• Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.

  2006cited by this paper
• Successful Stem Cell Therapy Using Umbilical Cord Blood‐Derived Multipotent Stem Cells for Buerger's Disease and Ischemic Limb Disease Animal Model

  2006influential reference
• Short-Term Heart Retention and Distribution of Intramyocardial Delivered Mesenchymal Cells within Necrotic or Intact Myocardium

  2006cited by this paper
• Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia

  2006cited by this paper
• ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography

  2006cited by this paper
• Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial.

  2006cited by this paper
• Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy

  2006cited by this paper
• Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.

  2006cited by this paper
• Autologous Bone Marrow Cell Therapy and Metabolic Intervention in Ischemia-Induced Angiogenesis in the Diabetic Mouse Hindlimb

  2006cited by this paper
• Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps.

  2006cited by this paper
• Human Adipose Tissue-Derived Mesenchymal Stem Cells Improve Postnatal Neovascularization in a Mouse Model of Hindlimb Ischemia

  2006cited by this paper
• Blood Monocytes Mimic Endothelial Progenitor Cells

  2006cited by this paper
• Left ventricular functional recovery with percutaneous, transvascular direct myocardial delivery of bone marrow-derived cells.

  2005cited by this paper
• PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells

  2005cited by this paper
• Unchain my heart: the scientific foundations of cardiac repair.

  2005cited by this paper
• PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells.

  2005cited by this paper
• Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia.

  2005cited by this paper
• Prevention of Limb Amputation in Patients with Limbs Ulcers by Autologous Peripheral Blood Mononuclear Cell Implantation

  2005influential reference
• Granulocyte-colony stimulating factor augments neovascularization induced by bone marrow transplantation in rat hindlimb ischemia.

  2005cited by this paper
• Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia.

  2005cited by this paper
• Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue–Derived Stromal Cells

  2005cited by this paper
• Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb.

  2005cited by this paper
• Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.

  2005cited by this paper
• Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.

  2005cited by this paper
• Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia.

  2005cited by this paper
• The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation.

  2005cited by this paper
• Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity.

  2004cited by this paper
• Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease

  2004cited by this paper
• Augmentation of Therapeutic Angiogenesis Using Genetically Modified Human Endothelial Progenitor Cells with Altered Glycogen Synthase Kinase-3β Activity*

  2004cited by this paper
• Collateral Growth in the Peripheral Circulation: A Review

  2004cited by this paper
• OXIDIZED LOW‐DENSITY LIPOPROTEIN INDUCES ENDOTHELIAL PROGENITOR CELL SENESCENCE, LEADING TO CELLULAR DYSFUNCTION

  2004cited by this paper
• Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms

  2004influential reference
• No effect of stem cell mobilization with GM-CSF on infarct size and left ventricular function in experimental acute myocardial infarction

  2004cited by this paper
• Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers

  2004cited by this paper
• Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells.

  2004cited by this paper
• Elevated Fluid Shear Stress Enhances Postocclusive Collateral Artery Growth and Gene Expression in the Pig Hind Limb

  2004cited by this paper
• A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware.

  2004cited by this paper
• Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms

  2004influential reference
• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

  2004influential reference
• Autologous skeletal myoblasts transduced with a new adenoviral bicistronic vector for treatment of hind limb ischemia.

  2004cited by this paper
• Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

  2004cited by this paper
• Endothelial Progenitor Cells: Characterization and Role in Vascular Biology Bone Marrow–Derived Cells for Enhancing Collateral Development: Mechanisms, Animal Data, and Initial Clinical Experiences Arteriogenesis Innate Immunity and Angiogenesis Syndecans Growth Factors and Blood Vessels: Differenti

  2004cited by this paper

• Efficacy of the combination of umbilical fat and venous blood on limb salvage

  2026cites this paper
• Cutting-edge approaches to diagnosing and treating limb ischemia in peripheral arterial disease

  2025cites this paper
• Translational Relevance of Advanced Age and Atherosclerosis in Preclinical Trials of Biotherapies for Peripheral Artery Disease

  2024cites this paper
• Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?

  2023cites this paper
• Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI)

  2023cites this paper
• Comparison of the impact of autologous cell therapy and conservative standard treatment on tissue oxygen supply and course of the diabetic foot in patients with chronic limb-threatening ischemia: A randomized controlled trial

  2022cites this paper
• Role of Lipid-Lowering Therapy in Peripheral Artery Disease

  2022cites this paper
• Acute multidrug delivery via a wearable bioreactor facilitates long-term limb regeneration and functional recovery in adult Xenopus laevis

  2022cites this paper
• The relation between adipose-derived stem cells and wound healing process - the review

  2022cites this paper
• Effect of tibial transverse transport on chronic lower extremity angiopathy: a protocol for a systematic review and meta-analysis

  2022cites this paper
• Cord Lining Mesenchymal Stem Cells Have a Modest Positive Effect on Angiogenesis in Hindlimb Ischemia

  2021influential citation
• Experimental Modeling of the Ultra-Necrotic Stage of Critical Ischemia of the Lower Limbs

  2021cites this paper
• Dose optimization of decellularized skeletal muscle extracellular matrix hydrogels for improving perfusion and subsequent validation in an aged hindlimb ischemia model.

  2020cites this paper
• Bone Marrow-Derived Cells: From the Laboratory to the Clinic

  2020cites this paper
• High Oxygen Preservation Hydrogels to Augment Cell Survival under Hypoxic Condition.

  2020cites this paper
• Autologous bone marrow mononuclear cell transplantation in patients with chronic traumatic brain injury- a clinical study

  2020cites this paper
• Autologous Bone-Marrow vs. Peripheral Blood Mononuclear Cells Therapy for Peripheral Artery Disease in Diabetic Patients

  2020cites this paper
• The Rationale of Autologously Prepared Bone Marrow Aspirate Concentrate for use in Regenerative Medicine Applications

  2020cites this paper
• Healing potential of injectable Aloe vera hydrogel loaded by adipose-derived stem cell in skin tissue-engineering in a rat burn wound model

  2019cites this paper
• Autologous Platelet-Rich Plasma and Mesenchymal Stem Cells for the Treatment of Chronic Wounds Autologous Platelet-Rich Plasma and Mesenchymal Stem Cells for the Treatment of Chronic Wounds

  2019cites this paper
• One-year results of the treatment of critical lower limb ischemia with indirect revascularization methods

  2019cites this paper
• In Vivo Photoacoustic Tracking of Mesenchymal Stem Cell Viability.

  2019cites this paper
• ОДНОЛЕТНИЕ РЕЗУЛЬТАТЫ ЛЕЧЕНИЯ КРИТИЧЕСКОЙ ИШЕМИИ НИЖНИХ КОНЕЧНОСТЕЙ СПОСОБАМИ НЕПРЯМОЙ РЕВАСКУЛЯРИЗАЦИИ

  2019cites this paper
• Impact of severe diabetic kidney disease on the clinical outcome of autologous cell therapy in people with diabetes and critical limb ischaemia

  2019cites this paper
• Growth hormone-releasing hormone promotes therapeutic effects of peripheral blood endothelial progenitor cells in ischemic repair

  2019influential citation
• Conversion of human adipose-derived stem cells into functional and expandable endothelial-like cells for cell-based therapies

  2018cites this paper
• Perfusion scintigraphy in the assessment of autologous cell therapy in diabetic patients with critical limb ischemia.

  2018cites this paper
• Inhibition of Aldehyde Dehydrogenase‐Activity Expands Multipotent Myeloid Progenitor Cells with Vascular Regenerative Function

  2018cites this paper
• The march of pluripotent stem cells in cardiovascular regenerative medicine

  2018cites this paper
• Microarray analysis for delineating the gene expression in biopsies of gastrocnemius muscle of patients with chronic critical limb ischaemia compared with non-ischaemic controls.

  2018cites this paper
• Hepatocyte Growth Factor Gene Therapy for Ischemic Diseases

  2018cites this paper
• Comparative Study between Intramuscular and Intra-Arterial Autologous Transplantation of Bone Marrow Derived Mononuclear Cells in Treatment of Non Reconstructable Critical Limb Ischemia

  2018cites this paper
• Critical limb ischemia: current challenges and future prospects

  2018cites this paper
• Difference in Serum Endostatin Levels in Diabetic Patients with Critical Limb Ischemia Treated by Autologous Cell Therapy or Percutaneous Transluminal Angioplasty

  2018cites this paper
• Autologous Platelet-Rich Plasma and Mesenchymal Stem Cells for the Treatment of Chronic Wounds

  2018cites this paper
• Stem Cell Therapies in Peripheral Vascular Diseases — Current Status

  2017cites this paper
• Stem Cell Therapies in Ischemic Stroke

  2017cites this paper
• Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products.

  2017cites this paper
• Non-reconstructable peripheral vascular disease of the lower extremity in ten patients treated with adipose-derived stromal vascular fraction cells.

  2017cites this paper
• Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia

  2017cites this paper
• A Molecular and Clinical Review of Stem Cell Therapy in Critical Limb Ischemia

  2017cites this paper
• Enzyme-Targeted Nanoparticles for Delivery to Ischemic Skeletal Muscle.

  2017cites this paper
• EFFECTS OF DIRECT AND INDIRECT DELIVERY OF THE VEGF GENE BY CORD BLOOD CELLS IN LIMB ISCHEMIA AREA IN RATS

  2017cites this paper
• The biological and clinical basis for the use of adipose-derived stem cells in the field of wound healing

  2017cites this paper
• Therapeutic Angiogenesis for Peripheral Artery Disease

  2017cites this paper
• Cell therapy of critical limb ischemia in diabetic patients - State of art.

  2017cites this paper
• Uso de células pluripotenciales en el tratamiento de la isquemia crítica

  2017cites this paper
• Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System

  2017cites this paper
• Regenerative Cell Therapy: Historical Background and Future Directions

  2016cites this paper
• Mesenchymal Stem Cells for Treatment of Peripheral Vascular Disease

  2016cites this paper
• Cardiosphere-Derived Cells Reverse Heart Failure With Preserved Ejection Fraction in Rats by Decreasing Fibrosis and Inflammation

  2016influential citation
• Angiogénesis terapéutica con células madre en pacientes con enfermedad arterial oclusiva crónica del Hospital Militar Central, impacto clínico luego de seis años

  2016cites this paper
• In vitro models for assessing therapeutic angiogenesis.

  2016cites this paper
• The diabetic foot in 2015: an overview

  2016cites this paper
• Therapeutic assessment of mesenchymal stem cells delivered within a PEGylated fibrin gel following an ischemic injury.

  2016cites this paper
• Administration of Adult Human Bone Marrow‐Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger’s Disease: Phase II Study Report Suggests Clinical Efficacy

  2016cites this paper
• Extracellular Matrix Hydrogel Promotes Tissue Remodeling, Arteriogenesis, and Perfusion in a Rat Hindlimb Ischemia Model

  2016cites this paper
• Stimulation of Neovasculogenesis as a Treatment of Chronic Obliterating Diseases of Arteries of Lower Extremities

  2016cites this paper
• Aging impairs ischemia-induced neovascularization by attenuating the mobilization of bone marrow-derived angiogenic cells

  2016cites this paper
• Bone Marrow–Derived Cells: From the Laboratory to the Clinic

  2016cites this paper
• Autologous transplantation of CD34+ bone marrow derived mononuclear cells in management of non-reconstructable critical lower limb ischemia

  2016cites this paper
• Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice.

  2016cites this paper
• Therapeutic efficacy of apelin on transplanted mesenchymal stem cells in hindlimb ischemic mice via regulation of autophagy

  2016cites this paper
• Wound management of chronic diabetic foot ulcers: From the basics to regenerative medicine

  2015cites this paper
• Attenuation of Hindlimb Ischemia after Associated Autologous Transplantation of Bone Marrow Mononuclear Cells and Platelet Rich Plasma

  2015cites this paper
• Imaging of Small Animal Peripheral Artery Disease Models: Recent Advancements and Translational Potential

  2015cites this paper
• A Review of the Pathophysiology and Potential Biomarkers for Peripheral Artery Disease

  2015cites this paper
• (2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis

  2015cites this paper
• Cell therapy attempted as a novel approach for chronic traumatic brain injury – a pilot study

  2015cites this paper
• Adequate Selection of a Therapeutic Site Enables Efficient Development of Collateral Vessels in Angiogenic Treatment With Bone Marrow Mononuclear Cells

  2015cites this paper
• Micro- and Nanoparticles for Treating Cardiovascular Disease.

  2015cites this paper
• Delivery of a Cell Patch of Cocultured Endothelial Cells and Smooth Muscle Cells Using Thermoresponsive Hydrogels for Enhanced Angiogenesis

  2015cites this paper
• Становление и развитие метода терапевтического ангиогенеза в российской сердечно-сосудистой хирургии

  2015cites this paper
• TLR 4 Deters Perfusion Recovery and Upregulates Toll-like Receptor 2 ( TLR 2 ) in Ischemic Skeletal Muscle and Endothelial Cells

  2015cites this paper
• TLR4 Deters Perfusion Recovery and Upregulates Toll-like Receptor 2 (TLR2) in Ischemic Skeletal Muscle and Endothelial Cells

  2015cites this paper
• Role of angiogenesis and angiogenic factors in acute and chronic wound healing

  2015cites this paper
• Meta-analysis of coronary artery bypass graft surgery combined with stem cell transplantation in the treatment of ischemic heart diseases

  2015cites this paper
• Therapeutic Angiogenesis in Ischemic Tissues by Growth Factors and Bone Marrow Mononuclear Cells Administration: Biological Foundation and Clinical Prospects.

  2015cites this paper
• Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs.

  2015cites this paper
• Stem Cells For The Treatment of Complex Regional Pain Syndrome (CRPS)/ Reflex Sympathetic Dystrophy (RSD): a case study

  2014cites this paper
• Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8

  2014influential citation
• A unique method for the isolation of nasal olfactory stem cells in living rats.

  2014cites this paper
• Endothelial progenitors.

  2014cites this paper
• Primed 3D injectable microniches enabling low-dosage cell therapy for critical limb ischemia

  2014cites this paper
• Role of Serum Levels of Angiogenic Cytokines in Assessment of Angiogenesis after Stem Cell Therapy of Diabetic Patients with Critical Limb Ischemia

  2014influential citation
• Basics of Adult Stem Cells, Mesenchymal and Hematopoietic Stem Cells for Future Clinical Application

  2014cites this paper
• Assessment of Tissue Perfusion in the Lower Limb: Current Methods and Techniques Under Development

  2014cites this paper
• Ca2+ signalling in endothelial progenitor cells: a novel means to improve cell-based therapy and impair tumour vascularisation.

  2014cites this paper
• New modalities in the chronic ischemic diabetic foot management.

  2014cites this paper
• Tetanus Toxoid‐Pulsed Monocyte Vaccination for Augmentation of Collateral Vessel Growth

  2014cites this paper
• Cellular Therapy Targeting Functional Outcome in a Case of Cervical Spinal Cord Injury

  2014cites this paper
• The role of nanotechnology in induced pluripotent and embryonic stem cells research.

  2014cites this paper
• Clinical-Grade Human Neural Stem Cells Promote Reparative Neovascularization in Mouse Models of Hindlimb Ischemia

  2014influential citation
• Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia.

  2014cites this paper
• The effect of local thermotherapy on pain severity in patients with chronic peripheral arterial occlusive disorders

  2014cites this paper
• Autologous G-CSF-Mobilized Peripheral Blood CD34+ Cell Therapy for Diabetic Patients with Chronic Nonhealing Ulcer

  2014cites this paper
• γ-Irradiated cord blood MNCs: different paracrine effects on mature and progenitor endothelial cells.

  2014cites this paper
• Stem Cells and Their Niches in Angiogenesis: Vascular Endothelial Stem Cells, Hematopoietic Progenitors and Hematopoietic Effector Cells

  2014cites this paper
• Primed 3 D injectable microniches enabling low-dosage cell therapy for critical limb ischemia

  2014cites this paper
• Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.

  2014cites this paper